Uzara® (Usara)

Archive
"Trade product
in Russia is not registered "
Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspcoated tablets
Composition:1 tablet contains:
active ingredient: Usara of roots extract dry (4-6: 1) - (in terms of Uzarin) 40 mg, extractant 60% methyl alcohol;
auxiliary ingredients: core tablet - wheat starch, lactose monohydrate, starch from locust bean seeds, talc, silicon dioxide colloidal anhydrous (colloidal anhydrous silicon), magnesium stearate; tablet shell - calcium carbonate, glucose syrup (dry matter), magnesium oxide, light corn starch (Snowflake 06598), castor oil, sucrose, shellac, talc, titanium dioxide E 171, mountain glycine wax.
Description:Round, biconvex tablets, coated with a coat of white. The core of the tablet is from light brown to brown with white impregnations.
Pharmacotherapeutic group:Antidiarrhoeic remedy
ATX: & nbsp
  • Drugs that reduce the peristalsis of the digestive tract
    • Pharmacodynamics:The antidiarrhoeal effect of Uzara® is associated with stimulation of the sympathetic nervous system with glycosides (active ingredients of Uzara®), which results in a weakening of the intestinal motility and normalization of the stool.
    In addition to suppressing the motility of the digestive tract, the active substances of Uzara® have antispasmodic, antisecretory,astringent and enveloping effects.
    Indications:Nonspecific acute diarrhea.
    Contraindications:Hypersensitivity to the components of the drug, simultaneous reception of cardiac glycosides, alcoholism, children's age (up to 12 years).
    Pregnancy and lactation:In experimental studies, there were no teratogenic, mutagenic properties of Uzar®. Until now, there have been no reports of any developmental defects in the use of the drug. Since the clinical experience of using the drug in pregnant and lactating women is very limited, the Uzara® drug should only be used, according to strict indications, when the intended benefit to the mother exceeds the potential risk to the fetus and the baby.
    Dosing and Administration:Inside, regardless of food intake.
    Adults and children over 12 years of age: the initial dose on the first day - 5 tablets (200 mg) once, in the following days - 1 tablet (40 mg) 3-6 times a day before the normalization of the stool. It is recommended to drink tablets with a small amount of liquid.
    Side effects:Allergic reactions.
    Interaction:With simultaneous use with drugs of quinidine, calcium,diuretics (saluretics) or long-term therapy with cortisone preparations may cause heart rhythm disturbances.
    Special instructions:If the duration of diarrhea exceeds 2 days, it is accompanied by high body temperature, and if there are impurities in the stool, you should immediately consult a doctor.
    Form release / dosage:tablets, coated with 40 mg
    Packaging:10 tablets per contour cell pack. Two or five contour squares, together with instructions for medical use of the drug, are placed in a cardboard pack.
    Storage conditions:At a temperature of no higher than 25 ° C.
    In a place inaccessible to children.
    Shelf life:3 years. Do not use the drug after the expiration date.
    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-003626/10
    Date of registration:30.04.2010
    Date of cancellation:2017-08-29
    The owner of the registration certificate:SHTADA Artznajmittel AGSHTADA Artznajmittel AG Germany
    Manufacturer: & nbsp
    Representation: & nbspNizhpharm, JSCNizhpharm, JSCRussia
    Information update date: & nbsp29.08.2017
    Illustrated instructions
      Instructions
      Up